17β-Estradiol inhibits prostaglandin E2-induced COX-2 expressions and cell migration by suppressing Akt and ERK1/2 signaling pathways in human LoVo colon cancer cells

Molecular and Cellular Biochemistry

Volumn 342, Issue 1-2, 2010, Pages 63-70

  Lai, Tung Yuan ^a,b   Chen, Li Mien ^c   Lin, Jing Ying ^d   Tzang, Bor Show ^e   Lin, James A ^a   Tsai, Chang Hai ^f   Lin, Yueh Min ^g   Huang, Chih Yang ^a,f   Liu, Chung Jung ^a   Hsu, Hsi Hsien ^h,i  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Taichung Hospital   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

^g CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^h MACKAY MEMORIAL HOSPITAL   (Taiwan)

ⁱ NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

Cell motility; COX 2; Estrogen; Human colon cancer cell; Prostaglandin E2

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOOXYGENASE 2; ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN E2; PROTEIN KINASE B; QNZ; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE 1; PTGS2 PROTEIN, HUMAN;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CELL STRAIN LOVO; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NUCLEOTIDE SEQUENCE; UPREGULATION; CELL MOTION; CHEMISTRY; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOBLOTTING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

CELL MOVEMENT; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; ESTRADIOL; HUMANS; IMMUNOBLOTTING; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 77955853644     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0469-7     Document Type: Article

References (33)

1. A Jemal T Murray E Ward A Samuels RC Tiwari A Ghafoor, et al. 2005 Cancer statistics CA Cancer J Clin 55 10 30 10.3322/canjclin.55.1.10 15661684
2. P Greenwald 1992 Colon cancer overview Cancer 70 5 1206 1215 10.1002/1097-0142(19920901)70:3+<1206::AID-CNCR2820701504>3.0.CO;2-J 1:STN:280:DyaK38znvFKqtg%3D%3D 1511368
3. A Jemal A Thomas T Murray M Thun 2002 Cancer statistics CA Cancer J Clin 52 23 47 10.3322/canjclin.52.1.23 11814064
4. A Jemal RC Tiwari T Murray A Ghafoor A Samuels E Ward, et al. 2004 Cancer statistics CA Cancer J Clin 54 8 29 10.3322/canjclin.54.1.8 14974761
5. K Subbaramaiah AJ Dannenberg 2003 Cyclooxygenase 2: a molecular target for cancer prevention and treatment Trends Pharmacol Sci 24 96 102 10.1016/S0165-6147(02)00043-3 1:CAS:528:DC%2BD3sXmt1aktA%3D%3D 12559775 (Pubitemid 36135884)
6. JR Vane RM Botting 1998 Mechanism of action of nonsteroidal anti-inflammatory drugs Am J Med 104 2S 8S 10.1016/S0002-9343(97)00203-9 1:CAS:528:DyaK1cXivFajur4%3D 9572314 discussion 21S-22S (Pubitemid 28186987)
7. MA Hull SC Ko G Hawcroft 2004 Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol Cancer Ther 3 1031 1039 10.4161/cbt.3.10.1227 1:CAS:528:DC%2BD2cXmtleksL8%3D 15299086 (Pubitemid 39199598)
8. ET Jacobs PA Thompson ME Martinez 2007 Diet, gender, and colorectal neoplasia J Clin Gastroenterol 41 731 746 10.1097/MCG.0b013e3180338e56 17700421 (Pubitemid 47267759)
9. JA Katzenellenbogen BS Katzenellenbogen 1996 Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses Chem Biol 3 529 536 10.1016/S1074-5521(96)90143-X 1:CAS:528:DyaK28XkvFWgur8%3D 8807884 (Pubitemid 26324165)
10. M Campbell-Thompson IJ Lynch B Bhardwaj 2001 Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer Cancer Res 61 632 640 1:CAS:528:DC%2BD3MXht1Gmsbo%3D 11212261
11. M Gambacciani P Monteleone A Sacco AR Genazzani 2003 Hormone replacement therapy and endometrial, ovarian and colorectal cancer Best Pract Res Clin Endocrinol Metab 17 139 147 10.1016/S1521-690X(02)00086-6 1:CAS:528: DC%2BD3sXjsVOgtbw%3D 12763517
12. F Grodstein ME Martinez EA Platz E Giovannucci GA Colditz M Kautzky, et al. 1998 Postmenopausal hormone use and risk for colorectal cancer and adenoma Ann Intern Med 128 705 712 1:STN:280:DyaK1c3htlaltg%3D%3D 9556463
13. RT Chlebowski J Wactawski-Wende C Ritenbaugh FA Hubbell J Ascensao RJ Rodabough, et al. 2004 Estrogen plus progestin and colorectal cancer in postmenopausal women N Engl J Med 350 991 1004 10.1056/NEJMoa032071 1:CAS:528:DC%2BD2cXhvFGjs7g%3D 14999111 (Pubitemid 38269276)
14. EE Calle HL Miracle-McMahill MJ Thun CW Heath Jr 1995 Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women J Natl Cancer Inst 87 517 523 10.1093/jnci/87.7.517 1:STN:280:DyaK2M3it1Kmug%3D%3D 7707438
15. YH Hsieh TT Wu CY Huang YS Hsieh JM Hwang JY Liu 2007 p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells Cancer Res 67 4320 4327 10.1158/0008-5472.CAN-06-2486 1:CAS:528:DC%2BD2sXltVyrsLg%3D 17483345 (Pubitemid 46815080)
16. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN DuBois 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183 1188 1:STN:280: DyaK2M%2FhtFamsA%3D%3D 7926468
17. H Sheng J Shao SC Kirkland P Isakson RJ Coffey J Morrow, et al. 1997 Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2 J Clin Invest 99 2254 2259 10.1172/JCI119400 1:CAS:528:DyaK2sXjtFCitrc%3D 9151799
18. MJ Thun SJ Henley C Patrono 2002 Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues J Natl Cancer Inst 94 252 266 1:CAS:528:DC%2BD38Xit1ygtb8%3D 11854387
19. M Oshima JE Dinchuk SL Kargman H Oshima B Hancock E Kwong, et al. 1996 Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 803 809 10.1016/S0092-8674(00)81988-1 1:CAS:528:DyaK28XntlymsLc%3D 8945508 (Pubitemid 26404280)
20. M Oshima N Murai S Kargman M Arguello P Luk E Kwong, et al. 2001 Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor Cancer Res 61 1733 1740 1:CAS:528:DC%2BD3MXhvVeksr4%3D 11245490
21. G Steinbach PM Lynch RK Phillips MH Wallace E Hawk GB Gordon, et al. 2000 The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 1946 1952 10.1056/NEJM200006293422603 1:CAS:528:DC%2BD3cXltVCnu7Y%3D 10874062 (Pubitemid 30419089)
22. WL Smith DL DeWitt RM Garavito 2000 Cyclooxygenases: structural, cellular, and molecular biology Annu Rev Biochem 69 145 182 10.1146/annurev. biochem.69.1.145 1:CAS:528:DC%2BD3cXnt1ajtLg%3D 10966456
23. F Zhang K Subbaramaiah N Altorki AJ Dannenberg 1998 Dihydroxy bile acids activate the transcription of cyclooxygenase-2 J Biol Chem 273 2424 2428 10.1074/jbc.273.4.2424 1:CAS:528:DyaK1cXnsVyhtQ%3D%3D 9442092 (Pubitemid 28069301)
24. K Subbaramaiah JC Hart L Norton AJ Dannenberg 2000 Microtubule- interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways J Biol Chem 275 14838 14845 10.1074/jbc.275.20.14838 1:CAS:528:DC%2BD3cXjsFantrg%3D 10809726 (Pubitemid 30337196)
25. K Subbaramaiah PA Cole AJ Dannenberg 2002 Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms Cancer Res 62 2522 2530 1:CAS:528:DC%2BD38XjtlGrsbo%3D 11980644
26. Z Zhang H Sheng J Shao RD Beauchamp RN DuBois 2000 Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells Neoplasia 2 523 530 10.1038/sj.neo.7900117 1:CAS:528:DC%2BD3MXoslGhug%3D%3D 11228545
27. M Marino P Galluzzo P Ascenzi 2006 Estrogen signaling multiple pathways to impact gene transcription Curr Genomics 7 497 508 10.2174/138920206779315737 1:CAS:528:DC%2BD2sXhtFGhs7s%3D 18369406 (Pubitemid 46068961)
28. J Mao Z Xu Y Fang H Wang J Xu J Ye, et al. 2008 Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation Cancer Sci 99 2120 2127 10.1111/j.1349-7006.2008.00928.x 1:CAS:528:DC%2BD1cXhsVKgtLrP 18823380
29. CI Schwer AM Guerrero M Humar M Roesslein U Goebel P Stoll, et al. 2008 Heme oxygenase-1 inhibits the proliferation of pancreatic stellate cells by repression of the ERK1/2 pathway J Pharmacol Exp Ther 327 863 871 10.1124/jpet.108.136549 1:CAS:528:DC%2BD1cXhsVCjtLjJ 18784349
30. SJ Lee SS Park US Lee WJ Kim SK Moon 2008 Signaling pathway for TNF-alpha-induced MMP-9 expression: Mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells Int Immunopharmacol 8 1821 1826 10.1016/j.intimp.2008.08.018 1:CAS:528:DC%2BD1cXhtlGht7nE 18801463
31. GT Kwon HJ Cho WY Chung KK Park A Moon JH Park 2009 Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling J Nutr Biochem 20 663 676 10.1016/j.jnutbio.2008. 06.005 1:CAS:528:DC%2BD1MXhtVSntrbK 18824345
32. HY Zhou KF Wan CK Ip CK Wong NK Mak KW Lo, et al. 2008 Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3 K and JNK FEBS Lett 582 3415 3422 10.1016/j.febslet.2008.09.004 1:CAS:528:DC%2BD1cXht1SnurvN 18789327
33. T Stankovic E Marston 2008 Molecular mechanisms involved in chemoresistance in paediatric acute lymphoblastic leukaemia Srp Arh Celok Lek 136 187 192 10.2298/SARH0804187S 18720757